IRIS Accounts Production v24.3.0.553 11245815 director 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112458152023-03-31112458152024-03-31112458152023-04-012024-03-31112458152022-03-31112458152022-04-012023-03-31112458152023-03-3111245815ns15:EnglandWales2023-04-012024-03-3111245815ns14:PoundSterling2023-04-012024-03-3111245815ns10:Director12023-04-012024-03-3111245815ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3111245815ns10:SmallEntities2023-04-012024-03-3111245815ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3111245815ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3111245815ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111245815ns10:FullAccounts2023-04-012024-03-3111245815ns10:CompanySecretary12023-04-012024-03-3111245815ns10:RegisteredOffice2023-04-012024-03-3111245815ns5:CurrentFinancialInstruments2024-03-3111245815ns5:CurrentFinancialInstruments2023-03-3111245815ns5:ShareCapital2024-03-3111245815ns5:ShareCapital2023-03-3111245815ns5:RetainedEarningsAccumulatedLosses2024-03-3111245815ns5:RetainedEarningsAccumulatedLosses2023-03-3111245815ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3111245815ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31112458151ns10:Director12023-03-31112458151ns10:Director12022-03-31112458151ns10:Director12023-04-012024-03-31112458151ns10:Director12022-04-012023-03-31112458151ns10:Director12024-03-31112458151ns10:Director12023-03-31
REGISTERED NUMBER: 11245815 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

Bioresonance Limited

Bioresonance Limited (Registered number: 11245815)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Bioresonance Limited

Company Information
for the Year Ended 31 March 2024







DIRECTOR: D R Franklin





SECRETARY: Mrs S D Franklin





REGISTERED OFFICE: 22 Layton Lane
Rawdon
Leeds
West Yorkshire
LS19 6RG





REGISTERED NUMBER: 11245815 (England and Wales)






Bioresonance Limited (Registered number: 11245815)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £   
CURRENT ASSETS
Debtors 4 4,282 4,982
Cash at bank 916 2,873
5,198 7,855
CREDITORS
Amounts falling due within one year 5 13,100 12,625
NET CURRENT LIABILITIES (7,902 ) (4,770 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(7,902

)

(4,770

)

CAPITAL AND RESERVES
Called up share capital 102 102
Retained earnings (8,004 ) (4,872 )
(7,902 ) (4,770 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 August 2024 and were signed by:





D R Franklin - Director


Bioresonance Limited (Registered number: 11245815)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Bioresonance Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The director's have confirmed they will continue to support the company where needed therefore the going concern basis is suitable.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

Bioresonance Limited (Registered number: 11245815)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 390 1,003
Other debtors - 342
Directors' current accounts 3,060 2,775
Tax 832 862
4,282 4,982

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors - 1,779
Taxation and social security 883 -
Other creditors 12,217 10,846
13,100 12,625

6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

31.3.24 31.3.23
£    £   
D R Franklin
Balance outstanding at start of year 1,214 -
Amounts advanced 802 1,214
Amounts repaid (517 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,499 1,214

7. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.